Streetbeat News

Stock Prices

OMGA

Omega Therapeutics' stock is trading higher following the announcement of a research collaboration with Novo Nordisk. This partnership could potentially lead to advancements in Omega's therapeutic programs and provide financial and strategic benefits.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:20 pm

AAPL

CORN

INTC

LLY

MARA

META

QQQ

TSLA

ZIM

Swaggy Stocks has listed the top 10 trending stocks on WallStreetBets as of January 4, 2024. The stocks include Apple Inc. (AAPL), Tesla Inc. (TSLA), Marathon Digital Holdings Inc. (MARA), Invesco QQQ Trust (QQQ), Deere & Company (DE), Teucrium Corn Fund (CORN), Intel Corporation (INTC), Meta Platforms Inc. (META), ZIM Integrated Shipping Services Ltd. (ZIM), and Eli Lilly and Company (LLY).

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:17 pm

FRES

Fresh2 Group Ltd. (NASDAQ:FRES) has signed an agreement to acquire Youfood Group Inc., a cross-border e-commerce food platform. The acquisition will be made through the exchange of 38,333,334 newly issued shares of Fresh2's Class A common stock. This move aims to connect Asian and South American food resources with North American customers, enhancing Fresh2's customer base and expanding its food supply chain ecosystem.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:17 pm

DAN

DHI

ITB

KMX

LEN

PHM

QQQ

SPY

Analysts at Nomura predict a 'mild recession' in the second half of 2024, impacting homebuilders and auto stocks due to tight financial conditions. Equity markets have retreated in 2024, with concerns over an economic slowdown affecting corporate earnings. The SPDR S&P 500 ETF (SPY) and Invesco QQQ Trust (QQQ) showed slight pre-market gains after recent losses. Homebuilders like DR Horton (DHI), Lennar (LEN), and Pulte Group (PHM) face risks from high mortgage rates and a potential slowdown in housing markets. The iShares U.S. Home Construction ETF (ITB) also declined after a strong 2023. The labor market is cooling, with potential increases in unemployment rates. Consumer spending is expected to slow, with rising credit card delinquency rates and the resumption of student loan repayments. Auto stocks like CarMax (KMX), Ford Motors (F), and Dana Inc (DAN) have already seen declines in early 2024.

Portfolio Pulse from Neil Dennis

January 04, 2024 | 2:17 pm

CRRFY

PEP

Carrefour SA has decided to stop selling PepsiCo products in its French stores due to what it considers 'unacceptable price increases.' This decision follows PepsiCo's announcement of modest price hikes earlier in October. The move is part of a larger trend where retailers are pushing back against price increases from consumer goods companies. The French government is also taking steps to combat inflation by urging earlier price negotiations. Carrefour's stock (CRRFY) closed lower by 1.08% at $3.66 on Wednesday.

Portfolio Pulse from Shivani Kumaresan

January 04, 2024 | 2:15 pm

LEXX

Lexaria Bioscience Corp. announced positive results from a human pilot study showing its DehydraTECH technology improved the oral delivery of the GLP-1 drug semaglutide, branded as Rybelsus. The study, conducted by a university research center, demonstrated that DehydraTECH-powered semaglutide achieved higher blood levels, better blood glucose control, faster peak drug delivery, and reduced side effects compared to the control. Lexaria is preparing for further studies to evaluate DehydraTECH's effectiveness with GLP-1 drugs.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:12 pm

COWZ

MCD

MRK

On CNBC's 'Halftime Report Final Trades,' Joseph Terranova recommended Merck & Co., despite the FDA's CRL on gefapixant for RCC and UCC. Stephanie Link expects McDonald's revenues to rise, citing legal action by GAR against BDS Malaysia and a Buy rating from HSBC with a $317 target. Bryn Talkington highlighted Pacer US Cash Cows 100 ETF's high free cash flow yield as a strong trade for 2024. Merck's stock rose 1.4%, McDonald's fell 0.9%, and COWZ dropped 0.5% on Wednesday.

Portfolio Pulse from Avi Kapoor

January 04, 2024 | 2:11 pm

ONCT

Oncternal Therapeutics has announced a 1-for-20 reverse stock split, which will be effective on January 8. This corporate action is typically used by companies to boost the share price by reducing the number of shares outstanding, which may help to meet exchange listing requirements or improve the stock's perception among investors.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:11 pm

TLRY

Tilray Brands, Inc. has expanded its cannabis beverage line with the introduction of RIFF BOOST, featuring two new THC and CBG-infused drink flavors. The drinks are now available in select regions in Canada. The company's stock, TLRY, traded higher in the pre-market session on the news. Additionally, Benzinga PotProfits highlighted potential growth in cannabis stocks, with Tilray's expansion being a part of the broader industry trend.

Portfolio Pulse from Jelena Martinovic

January 04, 2024 | 2:09 pm

XRTX

Alliance Global Partners analyst James Molloy has reaffirmed a Buy rating on XORTX Therapeutics (NASDAQ:XRTX) and increased the price target from $9 to $14, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 2:09 pm